BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27306217)

  • 1. Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.
    Muñiz-Hernández S; Huerta-Yepez S; Hernández-Pedro N; Ramírez-Tirado LA; Aviles-Salas A; Maldonado A; Hernández-Cueto D; Baay-Guzmán G; Arrieta O
    Int J Clin Oncol; 2016 Dec; 21(6):1051-1061. PubMed ID: 27306217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer.
    Tsuji K; Utsunomiya H; Miki Y; Hanihara M; Fue M; Takagi K; Nishimoto M; Suzuki F; Yaegashi N; Suzuki T; Ito K
    Int J Gynecol Cancer; 2017 May; 27(4):643-650. PubMed ID: 28375930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
    Mauro LV; Dalurzo M; Smith D; Lastiri J; Vasallo B; Joffei EB; Pallotta MG; Puricelli L
    Medicina (B Aires); 2008; 68(3):205-12. PubMed ID: 18689151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
    Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
    Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic p21sdi1 gene transfer induces retinoic acid receptor beta expression and sensitizes human cancer cells to retinoid treatment.
    Teraishi F; Kadowaki Y; Tango Y; Kawashima T; Umeoka T; Kagawa S; Tanaka N; Fujiwara T
    Int J Cancer; 2003 Mar; 103(6):833-9. PubMed ID: 12516107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.
    Song X; Shi K; Zhou SJ; Yu DP; Liu Z; Han Y
    Drug Des Devel Ther; 2016; 10():1345-54. PubMed ID: 27103788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
    Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
    Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
    Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
    Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid receptors in gastric cancer: expression and influence on prognosis.
    Hu KW; Chen FH; Ge JF; Cao LY; Li H
    Asian Pac J Cancer Prev; 2012; 13(5):1809-17. PubMed ID: 22901127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.
    Macedo-Pérez EO; Morales-Oyarvide V; Mendoza-García VO; Dorantes-Gallareta Y; Flores-Estrada D; Arrieta O
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):681-90. PubMed ID: 25059320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of retinoic acid receptor alpha, beta and gamma isoforms in the lizard, Podarcis sicula.
    Esposito T; Caccavo M; Cianci A; Cardone A; Angelini F; Varriale B
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):143-53. PubMed ID: 17449240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
    Du G; Yang Y; Zhang Y; Sun T; Liu W; Wang Y; Li J; Zhang H
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):893-904. PubMed ID: 23355038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
    Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
    Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.
    Li Y; Lu DG; Ma YM; Liu H
    Oncotarget; 2017 Jan; 8(4):5814-5822. PubMed ID: 28008143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer.
    Zhang T; Zhang DM; Zhao D; Hou XM; Yang TN
    J BUON; 2014; 19(3):742-8. PubMed ID: 25261661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.
    Cappuzzo F; Ciuleanu T; Stelmakh L; Cicenas S; Szczésna A; Juhász E; Esteban E; Molinier O; Brugger W; Melezínek I; Klingelschmitt G; Klughammer B; Giaccone G;
    Lancet Oncol; 2010 Jun; 11(6):521-9. PubMed ID: 20493771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients.
    Christoph DC; Reyna-Asuncion B; Hassan B; Tran C; Maltzman JD; O'Shannessy DJ; Gauler TC; Wohlschlaeger J; Schuler M; Eberhardt WE; Hirsch FR
    Clin Lung Cancer; 2014 Sep; 15(5):320-30.e1-3. PubMed ID: 24993594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.